U.S. Life Sciences Stock News

NasdaqGS:ZYME
NasdaqGS:ZYMEBiotechs

Zymeworks (ZYME) Is Up 5.4% After New FDA Approval Triggers $250 Million Milestone Payment

The U.S. FDA has approved Ziihera (zanidatamab-hrii), a bispecific HER2-targeting antibody, as a first-line treatment for adults with unresectable locally advanced or metastatic HER2-positive gastroesophageal adenocarcinoma, triggering a US$250 million regulatory milestone payment from Jazz Pharmaceuticals to Zymeworks. This second FDA approval for zanidatamab in under two years further validates Zymeworks’ Azymetric bispecific antibody platform and strengthens its royalty- and...
NYSE:JNJ
NYSE:JNJPharmaceuticals

Johnson & Johnson (JNJ) Wins FDA Approval For First Warm Autoimmune Hemolytic Anemia Treatment

Johnson & Johnson (NYSE: JNJ) received FDA approval for IMAAVY as the first treatment for adults with warm autoimmune hemolytic anemia, providing a new option for this rare blood disorder. The decision expands Johnson & Johnson's presence in rare diseases, with IMAAVY targeting patients who face limited existing therapies. In a separate development, a jury awarded a US$10 million verdict in a talc-related mesothelioma case against Johnson & Johnson, adding to its ongoing litigation...
NYSE:RCL
NYSE:RCLHospitality

Royal Caribbean Cruises (RCL), Why Is Fresh Attention Building Around It?

Royal Caribbean Cruises (RCL) lifted its earnings guidance for 2026 and signaled confidence in revenue growth, even as higher fuel costs and Iran related safety concerns continue to affect bookings and operating expenses. Royal Caribbean Cruises shares trade at US$292.29 and have eased in the short term, with the 7 day share price return down 2.57%. However, the 90 day share price return of 6.22% and a very large 5 year total shareholder return of 263.30% suggest longer term momentum has been...
NYSE:CNA
NYSE:CNAInsurance

Did Worsening Underwriting Metrics Amid Rising Premiums Just Shift CNA Financial's (CNA) Investment Narrative?

Recently, CNA Financial reported that while its premium volumes have been expanding, key insurance profitability indicators such as the combined ratio and core earnings have moved in an unfavorable direction. The company is leaning on selective underwriting, higher investment income, disciplined technology spending, and a solid capital position to support long-term earnings and ongoing dividend growth despite underwriting pressure. Next, we’ll examine how concerns over CNA’s underwriting...
NasdaqGM:RDNT
NasdaqGM:RDNTHealthcare

RadNet (RDNT) Could Be 17% Undervalued Following Its Recent Rally

RadNet (RDNT) has drawn investor attention after its recent share price moves, with the stock closing at US$76.86 and posting double digit total returns over the past month and past 3 months. Zooming out, RadNet’s recent share price momentum, including a 24.83% 30 day share price return and 42.76% 90 day share price return, sits alongside an 8.33% year to date share price return and a 135.26% 3 year total shareholder return. Together, these figures indicate building momentum from a longer...
NYSE:CRS
NYSE:CRSAerospace & Defense

Carpenter Technology (CRS) Could Be 22% Undervalued As Expansion Stays On Track

Carpenter Technology (CRS) is in focus after updating investors on its planned US$400 million brownfield expansion. The project is expected to lift specialty alloys production capacity by 7% by fiscal 2028. Carpenter Technology’s update on the brownfield expansion comes after a sharp pullback, with the 30 day share price return down 19.48% and the 7 day return down 8.62%. This is despite the year to date share price return of 43.67% and the 1 year total shareholder return of 101.40%. Compare...
NYSE:LLY
NYSE:LLYPharmaceuticals

Eli Lilly (LLY) Stock Trades Below Fair Value On Cash Flow

Eli Lilly stock has logged very strong gains over the past few years, yet the latest valuation checks send a mixed message about where fair value may sit. The intrinsic value estimate from a Discounted Cash Flow (DCF) model points to a meaningful discount, while the broader set of valuation checks does not present Eli Lilly as an obvious bargain or an obvious premium. Eli Lilly has delivered a return of about 399.8% over the past 5 years, which puts extra focus on whether the current share...
NYSE:TUYA
NYSE:TUYASoftware

What Tuya (TUYA)'s AI-Driven Smart Home Profit Uplift Means For Shareholders

Tuya Inc. reported past half-year 2026 results with sales rising to US$173.82 million from US$154.82 million and net income increasing to US$34.41 million from US$23.6 million, lifting basic and diluted EPS from US$0.04 to US$0.06. Management highlighted that stronger Platform-as-a-Service and AI-driven smart home demand, particularly in Europe, underpinned both revenue growth and improved profitability despite mixed regional conditions. Now we’ll examine how this profit uplift, supported by...
NasdaqGS:TOWN
NasdaqGS:TOWNBanks

Is TowneBank (TOWN) Undervalued After Its Recent Share Price Run?

TowneBank (TOWN) is back on investor radars after recent share price moves, prompting a closer look at how the regional lender’s current valuation and fundamentals line up for long term holders. Over the past year TowneBank’s share price has moved steadily higher, with a 90 day share price return of 10.93% and a year to date share price return of 13.67%. Total shareholder return over three years sits at 78.56% and 48.63% over five years, suggesting momentum has been building rather than...
NYSE:SARO
NYSE:SAROAerospace & Defense

StandardAero (SARO) Could Be 34% Below Fair Value As Air Force Deal Adds Support

StandardAero (SARO) stock is in focus after the company secured a new 10-year U.S. Air Force T56 engine depot maintenance contract with a ceiling value of US$342.2 million. Despite the new U.S. Air Force T56 contract, StandardAero’s share price has been under pressure in recent months. The 30 day share price return is down 13.03% and the year to date share price return is down 15.79%, while the 1 year total shareholder return is down 8.54%. This suggests momentum has been fading even as fresh...
NasdaqGS:NSSC
NasdaqGS:NSSCElectronic

Napco Security Technologies (NSSC) Stock Slips As Recurring Revenue Strength Faces Access Control Weakness

Napco Security Technologies stock slipped about 3% today to roughly US$36, even as the latest quarter delivered one of the strongest profit stories in the security hardware and services space. Revenue in Q4 reached US$55.8m and net income came in at US$17.8m, both tied to hefty margins that matter in a capital light, recurring revenue heavy model. Short term traders saw a red day on the screen. Longer term investors saw a company leaning on high margin recurring service revenue and solid cash...
NasdaqGS:EYE
NasdaqGS:EYESpecialty Retail

National Vision Holdings (EYE) Earnings Put Its Undervalued Narrative Back In Focus

National Vision Holdings (EYE) drew fresh attention on August 12 after reporting higher second quarter revenue of $498.81 million and net income of $12.42 million, along with updated full year guidance and a completed share repurchase tranche. At a share price of $18.69, National Vision Holdings has seen a 1-day share price return of 2.52%, while the 30-day share price return is down 6.17% and the year-to-date share price return is down 27.98%, pointing to fading momentum despite a 12.66%...
NYSE:PAYC
NYSE:PAYCProfessional Services

Paycom Software (PAYC) Rallies On AI And Automation Narrative As Valuation Questions Linger

Paycom Software (PAYC) has drawn investor attention after a strong month, with the stock returning about 59% over that period and roughly 75% over the past 3 months based on recent performance data. At a share price of $231.70, Paycom Software has seen strong recent momentum, with a 7-day share price return of 7.41% and a 30-day share price return of 59.41%. However, the 5-year total shareholder return shows a decline of 51.30%, which highlights how sharp the latest move has been relative to...
NYSE:NFG
NYSE:NFGGas Utilities

3 Defensive Dividend Stocks for Investors Seeking Shelter From Market Volatility

With U.S. stocks under pressure and growth expectations being questioned, many investors are quietly hunting for steadier ground. When technology and consumer discretionary stocks struggle, attention often shifts to large dividend payers and value stocks that some investors see as potential ballast for a tougher market mood. This article walks through three stocks from our Defensive, Dividend-Paying Value Stocks screener that appear particularly exposed to the latest inflation, earnings and...
NYSE:TX
NYSE:TXMetals and Mining

Ternium (TX) Stock Could Be Fully Priced As Cash Flow Recovery Matters

Ternium stock has delivered strong share price gains over the past year, yet the valuation picture is more nuanced, as the intrinsic value estimate points to roughly fair pricing while traditional earnings multiples screen the shares as cheaper than peers. That mix leaves Ternium looking less like a clear bargain and more like a stock where recent momentum and valuation checks need to be weighed together. Ternium has returned 75.7% over the past year, which puts recent share price strength...
NYSE:MSCI
NYSE:MSCICapital Markets

MSCI (MSCI) Stock Could Be 15% Undervalued On India Derivatives Push

MSCI’s share price has been relatively flat in the past year, yet valuation checks are split, with the Discounted Cash Flow (DCF) intrinsic value estimate pointing to some upside while market multiples suggest the stock is priced at a premium. MSCI has returned 8.8% over the past 3 years, which points to modest shareholder gains rather than an aggressive re rating. The new partnership with BSE to launch derivatives on MSCI indices may support expectations for index related revenue growth,...
NasdaqGM:TMDX
NasdaqGM:TMDXMedical Equipment

TransMedics (TMDX) Stock Looks Below Fair Value Though Governance Risks Weigh

TransMedics Group stock has delivered a strong 5 year gain, yet the broader valuation checks currently suggest the shares still lean cheap relative to fundamentals. Recent share price swings and legal headlines mean investors are weighing that high value score against fresh questions about governance and risk. Over the past 5 years, TransMedics Group has returned about 186.4%, which puts recent setbacks into a longer history of strong shareholder gains. An ongoing investigation into...
NYSE:CXT
NYSE:CXTElectronic

What Crane NXT (CXT)'s Leadership Shift in Payments and Detection Means For Shareholders

Earlier, Crane NXT appointed Jason Lund as President of Crane Payment Innovations and Group President of its Detection and Traceability Technologies segment, drawing on his background in operational excellence, mergers and acquisitions, and integration across several industrial and technology companies. This move brings in leadership experience from organisations such as Novanta, Vontier, Fortive and Danaher, potentially influencing how Crane NXT executes on operational and portfolio...
NasdaqGS:BAND
NasdaqGS:BANDTelecom

Bandwidth (BAND) Pulls Back Following Its Rally, But Is The Valuation Story Still Intact?

Bandwidth (BAND) has drawn fresh attention after recent share price swings, with the stock up about 2.3% over the past year but down over the past month and over the past three months. Recent share price moves suggest momentum in Bandwidth is fading in the short term, with a 7 day share price return of down 11.87% and a 30 day return of down 21.98%. However, the year to date share price return of 228.09% and 1 year total shareholder return of 227.40% still point to a much stronger longer term...
NasdaqGS:GLNG
NasdaqGS:GLNGOil and Gas

Is Golar LNG (GLNG) Undervalued As Strong Results And New FLNG Deals Land?

Golar LNG (GLNG) is back in focus after a packed August 13 update that combined second quarter and first half 2026 results with new floating LNG investment plans and a fresh dividend declaration. At a share price of $52.04, Golar LNG has seen a 7.03% one-month share price return and a 37.13% share price return year to date. The 5-year total shareholder return of 417.10% and 3-year total shareholder return above 160% highlight longer-term momentum supported by recent earnings, new FLNG...
NasdaqGS:AMAT
NasdaqGS:AMATSemiconductor

Applied Materials Stock And The Factory Buildout Investors May Be Missing

As Washington and Seoul talk less about missiles and more about factories, a new story is taking shape around where Korean capital is landing in the U.S. That shift, backed by large chip, EV, and shipyard projects, is quietly creating fresh winners across the infrastructure supply chain. This article walks through three U.S. stocks that appear closely tied to this news and explains how each might fit, or not fit, in your watchlist. The stocks in the article below are just a sample of what...
NasdaqGS:ZS
NasdaqGS:ZSSoftware

Is Zscaler’s (ZS) SMB Zero Trust Push With Carahsoft a New Chapter in Its Growth Story?

Earlier in August 2026, Zscaler and Carahsoft Technology Corp. expanded their partnership to extend the Zscaler Zero Trust Exchange platform into U.S. SMB and mid-market segments, offering standardized bundles, simplified pricing, and partner enablement to replace legacy, appliance-based security architectures with a unified cloud-delivered Zero Trust model. This move highlights how Zscaler is using channel partners and packaged Zero Trust offerings to reach underserved smaller...
NYSE:ARCO
NYSE:ARCOHospitality

Arcos Dorados Holdings (ARCO) Is Up 5.6% After Net Income More Than Doubled - What's Changed

In the half year ended June 30, 2026, Arcos Dorados Holdings Inc. reported revenue of US$2,521.6 million, up from US$2,218.89 million a year earlier, with net income rising to US$81.15 million and basic earnings per share from continuing operations increasing to US$0.39 from US$0.17. This sharp improvement in profitability suggests the company is converting higher sales into earnings more efficiently, which may influence how investors assess its earnings quality and operating...
NasdaqGS:RIVN
NasdaqGS:RIVNAuto

Why Rivian Automotive (RIVN) Is Back In The Spotlight

Rivian Automotive (RIVN) has caught investor attention after the stock moved above both its 50-day and 200-day moving averages, along with several upward earnings estimate revisions for the current fiscal year. At a latest share price of $16.74, Rivian Automotive has seen short term momentum pick up, with a 7 day share price return of 13.26% and a 90 day share price return of 13.88%, even though the year to date share price return is down 13.76% and the 3 year total shareholder return is down...